ORLANDO -- Putting type 2 diabetes patients on an automated insulin delivery (AID) pump improved glycemic control, the SECURE-T2D pivotal trial showed. Type 2 diabetes patients started on the Omnipod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback